SiddharthaGangulyMDFACP

Hematologic Oncology

Associate Director for Clinical Investigation and Research Chief, Division of Hematology. Houston Methodist Hospital and Neal Cancer Center, Houston, TX

Join to view full profile

Dr. Ganguly is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ganguly's full profile

Already have an account?

Office
6445 Main St
# Opc
Houston, TX 77030
Phone+1 713-441-9948

Fax+1 713-793-1642

Summary

Dr. Siddhartha Ganguly is a hematologist in Houston, TX and is affiliated with Houston Methodist Hospital. He received his medical degree from Medical College and Hospital Kolkata and has been in practice for over 30 years. He specializes in hematologic oncology and is experienced in bone marrow transplantation, multiple myeloma, lymphoma, and cellular immunotherapy. He has more than 150 publications and over 500 citings. He has been PI for many clinical trials and is the Associate Director for Clinical Investigation at the Houston Methodist Hospital and Neal Cancer Center.

Education & Training

Baylor College of MedicineResidency, Internal Medicine, 1994 - 1995
Southern Illinois UniversityInternship, Internal Medicine, 1993 - 1994
Medical College and Hospital KolkataClass of 1987
Baylor College of MedicineFellowship, Hematology

Certifications & Licensure

OR State Medical License 1999 - Present
TX State Medical License 2020 - 2026
KS State Medical License 1995 - 2025
WA State Medical License 1995 - 2010
IL State Medical License 1993 - 1996
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

Fellow (FACP) American College of Physicians, 2007
Outstanding Teacher Award University of Kansas Medical Center, 2005
Max S. Allen Clinical Scholar Award University of Kansas Medical Center, 2004
Second prize clinical vignettes Southern Chapter of American College of Physicians, 1995
Outstanding Resident Award, Internal Medicine SIU School of Medicine, 1994
Gold Medal, Anatomy Medical College, University of Calcutta, 1983
National Talent Search Scholarship 1982
Goodeve Silver Medal Medical College, University of Calcutta, 1982
Successive Four College Scholarships Medical College, University of Calcutta, 1982
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Evaluate Rituximab in Obtaining PCR (Polymerase Chain Reaction) Negative Leukapheresis Product in Patients With Relapsed Follicular Lymphoma Start of enrollment: 2009 Feb 01
Completed
Phase 2
Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine Start of enrollment: 2010 Jan 01
Completed
Early Phase 1
Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma Start of enrollment: 2009 Nov 12
Completed
Phase 1, Phase 2
Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) Start of enrollment: 2010 May 01
Completed
Phase 3
Telomere and Telomerase Start of enrollment: 2010 Sep 01
Withdrawn
Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT) Start of enrollment: 2015 Mar 01
Completed
Phase 3
Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Start of enrollment: 2016 Oct 12
Active, not recruiting
Phase 3
Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM) Start of enrollment: 2016 Mar 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

78 citations
A risk-based approach to optimize autologous hematopoietic stem cell (HSC) collection with the use of plerixafor
Sunil Abhyankar, Shaun DeJarnette, Omar S. Aljitawi, S Ganguly, Dean Merkel
Bone Marrow Transplantation. 2012-04-01
69 citations
Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR r...
Jeffrey Schriber, Parameswaran Hari, Kwang Woo Ahn, Mingwei Fei, Luciano J. Costa
Cancer. 2017-08-15
39 citations
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
Annie Im, Armin Rashidi, Tao Wang, Michael T. Hemmer, Margaret L. MacMillan
Biology of Blood and Marrow Transplantation. 2019-03-01

Journal Articles

Erythropoietin modulation is associated with improved homing and engraftment post umbilical cord blood transplantation
Aljitawi OS, Paul S, Ganguly A, Lin TL, Ganguly S, Vielhauer G, Capitano ML, Cantelina A, Lipe B, Mahnken JD, Wise A, Berry A, Singh AK, Shune L, Lominska C, Abhyankar..., Blood, 1/19/2016
Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched unrelated donors
Abraham S. Kanate, Alberto Mussett, Mohamed A. Kharfan-Dabaja, Kwang W. Ahn, Alyssa DiGilio,Amer Beitinjaneh , Saurabh Chhabra, Timothy S. Fenske, Cesar Freytes, Rober..., Blood, 1/18/2016
Post-transplant outcomes in high-risk compared to non-high risk multiple myeloma, a CIBMTR analysis
Scott EC, Hari P, Sharma M, Le-Rademacher J, Huang J, Vogl D, Abidi M, Beitinjaneh A, Fung H, Ganguly S, Hildebrandt G, Holmberg L, Kumar S, Kyle R, Lazarus HM, Lee C..., Biol Blood Marrow Transplant, 1/1/2016
Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched sibling donorsA CIBMTR analysis
Ghosh N, Karmali R, Rocha V, Ahn KW, DiGilio A, Hari PN, Bachanova V, Bacher U, Dahi P, de Lima M, D'Souza A, Fenske TS, Ganguly S, Kharfan-Dabaja MA, Prestidge TD, Sa..., J Clin Oncol, 1/1/2016
Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies
Pasquini MC, Zhang MJ, Medeiros BC, Armand P, Hu ZH, Nishihori T, Aljurf MD, Akpek G, Cahn JY, Cairo MS, Cerny J, Copelan EA, Deol A, Freytes CO, Gale RP, Ganguly S, G..., Biol Blood Marrow Transplant, 1/1/2016
Improved outcomes after autologous hematopoietic cell transplantation for light chain amyloidosis: A Center for International Blood and Marrow Transplant Research Study
Anita D'Souza, Angela Dispenzieri, Baldeep Wirk, Mei-Jie Zhang, Jiaxing Huang, Morie Gertz, Robert Kyle, Shaji Kumar, Raymond Comenzo, Robert Gale, Hillard Lazarus, Bi..., J Clin Oncol, 1/10/2015
Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the ASBMT
Shah N, Callander N, Ganguly S, Gul Z, Hamadani M, Costa L, Sengsayadeth S, Abidi M, Hari P, Mohty M, Chen YB, Koreth J, Landau H, Lazarus H, Leather H, Majhail N, Nat..., Biol Blood Marrow Transplantation, 1/1/2015
Impact of “real-world” interpretation of pre-transplant FDG-PET status on outcomes after allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma
Veronika Bachanova, Linda J. Burns, Kwang Woo Ahn, Ginna G. Laport, Görgün Akpek, , Mohamed A. Kharfan-Dabaja, Taiga Nishihori, Edward Agura, Philippe Armand, S..., Biol Blood Marrow Transplant, 1/1/2015
Targeting HSF1 disrupts HSP90 Chaperone Function in Chronic Lymphocytic Leukemia
Ganguly S, Home T, Yacoub A, Kambhampati S, Shi H, Dandwate P, Padhye S, Saluja AK, McGuirk J and Rao, Oncotarget., 1/1/2015
Adequacy of Peripheral Blood Stem Cell Mobilization in Patients with Relapsed B Cell Non Hodgkin Lymphoma Treated with Bendamustine
Iliff A, Divine C, Diaz, F, Aljitawi O, Abhyankar S, McGuirk J, and Ganguly S, Leuk Lymphoma, 1/1/2015
Reduced-intensity allografting as first transplantation approach in relapsed/refractory grade 1-2 follicular lymphoma provides improved outcomes in long-term survivors
Klyuchnikov E, Bacher U, Kröger N, Hari P, Ahn KW, Carreras J, Bachanova V, Bashey A, Cohen JB, D’Souza A, Freytes CO, Gale RP, Ganguly S, Hertzberg MS, HolmbergLS,..., Biol Blood Marrow Transplant, 1/1/2015
Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation
Uy GL, Costa LJ, Hari PN, Zhang MJ, Huang JX, Anderson KC, Bredeson CN, Callander NS, Cornell RF, Perez MA, Dispenzieri A, Freytes CO, Gale RP, Garfall A, Gertz MA, Gi..., Bone Marrow Transplant, 1/1/2015
A Prognostic Model Predicting Autologous Transplantation Outcomes in Children, Adolescents and Young Adults with Hodgkin Lymphoma
Satwani P, Ahn KW, Carreras J, Abdel-Azim H, Cairo MS, Cashen A, Chen AI, Cohen JB, Costa LJ, Dandoy C, Fenske TS, Freytes CO, Ganguly S, Gale RP, Ghosh N, Hertzberg M..., Bone Marrow Transplant, 1/1/2015
Routine Radiographic Screening after Completion of Initial Chemotherapy and Relapse-Free Survival after Transplantation in Patients with Relapsed Lymphoma
Ganguly S, McRae J, He J, Divine CL, Abhyankar S, Aljitawi O, and McGuirk JP, Leuk Lymphoma, 1/14/2014
Rituximab as a treatment for Factor VIII inhibitor in a patient with Chronic Graft Versus Host Disease
Wieliczka ML, Ganguly S, Abhyankar S, Lin T, McGuirk JP, Aljitawi OS, Bone Marrow Transplant, 1/1/2014
Phase IIa cross-over study of propylene glycol-free melphalan (LGD-353) and alkeran in multiple myeloma autologous transplantation
Aljitawi OS, Ganguly S, Abhyankar SH, Ferree M, Marks R, Pipkin JD, McGuirk JP, Bone Marrow Transplant, 1/1/2014
Intestinal Ischemia following Allogeneic Stem Cell Transplantation: A report of four cases
Lindsey Prochaska, James Vacek, Rashna Madan, Sunil Abhyankar, Sid Ganguly, Joseph P. McGuirk, Tara L. Lin, Omar S. Aljitawi, Transplant Proc, 1/1/2014
Pulmonary Manifestations of the Pre-Engraftment Syndrome after Umbilical Cord Blood Transplantation
Kyle R. Brownback, Steven Q. Simpson, Joseph P. McGuirk, Tara L. Lin, Sunil Abhyankar, Siddhartha Ganguly, and Omar S. Aljitawi, Ann Hematol, 1/1/2014
Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transpl...
Hamadani M, Hari PN, Zhang Y, Carreras J, Akpek G, Aljurf MD, Ayala E, Bachanova V, Chen AI, Chen YB, Costa LJ, Fenske TS, Freytes CO, Ganguly S, Hertzberg MS, Ho..., Biol Blood and Marrow Transplantation, 1/1/2014
Preclinical and phase I results of decitabine in combination with midostaurin (PKC412) for newly diagnosed elderly or relapsed/refractory adult patients with acute mye...
Williams CB, Kambhampati S, Fiskus W, Wick J, Dutreix C, Ganguly S, Aljitawi O, Reyes R, Fleming A, Abhyankar S, Bhalla KN, McGuirk JP, Pharmacotherapy, 1/1/2013
A Phase 2 Trial of Panobinostat, an Orally Available Pan-Deacetylase Inhibitor in Patients with Primary Myelofibrosis, Post Essential Thrombocythemia, and Post Polycyt...
Daniel J. DeAngelo, Ruben A. Mesa, Warren Fiskus, Ayalew Tefferi, Carole Paley, Martha Wadleigh, Ellen Ritchie, David S. Snyder, Kebede Begna, Siddhartha Ganguly, Mich..., Br J Haematol, 1/1/2013
Decitabine in Patients with Relapsed AML after Allogeneic BMT
Ganguly S, Amin M, Divine CL, Aljitawi OS, Abhyankar S, and McGuirk JP, Ann Hematol., 1/1/2013
Delayed RSV Diagnosis in a Stem Cell Transplant Population Due to Mutations that Result in Negative PCR
Dana Hawkinson, Sunil Abhyankar, Omar Aljitawi, Siddhartha Ganguly, Joseph P. McGuirk, and Rebecca Horvat, Diagn Microbiol Infect Dis, 1/1/2013
McGuirk Bendamustine Associated with Irreversible Ascending Paralysis
Ashraf Alhafez, Omar S.Aljitawi,Tara L. Lin, Siddhartha Ganguly, Sunil Abhyankar, and Joseph P, Case Rep Hematol, 1/1/2013
Clofarabine Plus Cytarabine Compared with Cytarabine Alone in Older Patients with Relapsed or Refractory Acute Myelogenous Leukemia: Results from the Randomized, Doubl...
Stefan Faderl, Meir Wetzler, David Rizzieri, Gary Schiller, Madan Jagasia, Robert Stuart, Siddhartha Ganguly, et al, Journal of Clinical Oncology, 1/10/2012
Join now to see all

Abstracts/Posters

Characterization of Response and Transfusion Independence in Patients with FLT3-Internal Tandem Duplication (FLT3-ITD)_Mutated Relapsed/Refractory Acute Myeloid Leukem...
Siddhartha Ganguly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Impact of Renal Dysfunction Measured By Estimated Glomerular Filtration Rate (eGFR) on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)
Siddhartha Ganguly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Preclinical Evaluation of Gilteritinib on NPM1-ALK Driven Anaplastic Large Cell Lymphoma Cells
Siddhartha Ganguly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Pooled Safety Analysis of Quizartinib Monotherapy in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)Clinically Relevant Abstract
Siddhartha Ganguly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Effect of Co-Mutations and FLT3-ITD Variant Allele Frequency (VAF) on Response to Quizartinib or Salvage Chemotherapy (SC) in Relapsed/Refractory (R/R) Acute Myeloid L...
Siddhartha Ganguly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Quality-Adjusted Time without Symptoms or Toxicity (Q-TWiST) Analysis of Quizartinib Vs Salvage Chemotherapy in Patients with Relapsed/Refractory (R/R) FLT3-ITD Acute ...
Siddhartha Ganguly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Targeted therapy for EBV-associated B-cell neoplasms
Siddhartha Ganuguly, Satyanarayana Alleboina, Sudhakiranmayi Kuravi, Joseph McGuirk, Ramesh Balusu, AACR Annual Meeting, New Orleans, LA, 1/19/2016
Transfusion support and post-transplant complications in autologous transplant patients receiving hyperbaric oxygen
Haitham Abdelhakim, Amy Cantilena, Tara L. Lin, Siddhartha Ganguly, Anurag Kumar Singh, Leyla Osman Shune, Sunil H. Abhyankar, Brea Lipe, Joseph McGuirk, Dennis Allin,..., ASCO, 1/1/2016
Outcomes of Autologous Stem Cell Transplantation for Lumphoma in the Elderly: A Single Center Experience
Singh AK, Mohyuddin GR, Shune L, Lin TL, Aljitawi O, Ganguly S, Abhyankar S, McGuirk JP, Biol Blood Marrow Transplantation, 1/1/2016
Allogeneic Hematopoietic Cell Transplantation for Adult T-cell Acute Lymphoblastic Leukemia (T-ALL)
Betty Ky Hamilton, Lisa Rybicki, Anjali S. Advani, Donna Abounader, Khoan Vu, Rizwan Romee, Simon B Zeichner, Christopher Flowers, Stacey Brown, Asad Bashey, Auro Visw..., BBMT, 1/1/2016
Basiliximab for the Treatment of Steroid Refractory Acute Graft-versus-Host -Disease following Allogeneic Stem Cell Transplantation
Mahmoudjafari Z, McGuirk J, Ganguly S, Aljitawi O, Lin T, Singh A, Shune L, Abhyankar S, BBMT, 1/1/2016
Transfusion support and post-transplant complications in autologous transplant patients receiving hyperbaric oxygen
Haitham Abdelhakim, Amy Cantilena, Tara L. Lin, Siddhartha Ganguly, Anurag Kumar Singh, Leyla Osman Shune, Sunil H. Abhyankar, Brea Lipe, Joseph McGuirk, Dennis Allin,..., J Clin Oncol, 1/1/2016
A pilot study using hyperbaric oxygen therapy to improve umbilical cord blood stem cell engraftment: 6-months follow up results
Alain Mina, Amy Cantilena, Tara L. Lin, Siddhartha Ganguly, Leyla Osman Shune, Amanda L. Wise, Anurag Singh, Sunil H. Abhyankar, Joseph McGuirk, Dennis Allin, Omar Sal..., ASCO Annual meeting, 1/1/2016
A pilot study using hyperbaric oxygen therapy to improve umbilical cord blood stem cell engraftment: 6-months follow up results
Alain Mina, Amy Cantilena, Tara L. Lin, Siddhartha Ganguly, Leyla Osman Shune, Amanda L. Wise, Anurag Singh, Sunil H. Abhyankar, Joseph McGuirk, Dennis Allin, Omar Sal..., J Clin Oncol, 1/1/2016
Severe acute graft versus host disease may complicate use of checkpoint blockade after allogeneic stem cell transplant in lymphoma patients
Bradley M. Haverkos MD, Jeffrey Schowinksy MD, Jeffrey B. Kaplan MD, Manali Kamdar MD, Abraham Sebastian Kanate MD, Ayman Saad MD, Siddhartha Ganguly MD, Mary Flowers ..., ASH Lymphoma Biology, Colorado Springs, CO, 1/1/2016
Impact of Hyperbaric Oxygen Treatment on Time to Transfusion Independency Post-UCB Transplant
Amy Rose Cantilena, BS, Tara L. Lin, Siddhartha Ganguly, Leyla Shune, Anurag K. Singh, Sunil Abhyankar, Jonathan Mahnken, Dennis Allin, Joseph McGuirk, and Omar S. Alj..., American Society of Hematology Annual Meeting, Orlando, FL, 1/9/2015
Final Results of the First-in-Human Clinical Study Incorporating Hyperbaric Oxygen into Umbilical Cord Blood Transplantation
Omar S. Aljitawi, Siddhartha Ganguly, Tara L. Lin, Shana Palla, Chris Lominska, Qing Yu, Singh Anurag, Sunil Abhyankar, Dennis Allin, Mary Eapen, and Joseph McGuirk, American Society of Hematology Annual Meeting, Orlando, FL, 1/9/2015
Pre-clinical evaluation of ceritinib in anaplastic large cell lymphoma
Siddhartha Ganguly, Sudhakiranmayi Kuravi, Satyanarayana Alleboina, Brandon Weckbaugh, Deepti Satelli, Jensen Roy, Scott Weir, Joseph McGuirk, Ramesh Balusu. Universit..., AACR, Philadelphia, PA, 1/1/2015
In Vivo Purging May Not Be Required In The ERA Of Universal Use Of Rituximab Containing Chemo-Immunotherapy In Patients With Follicular And Mantle Cell Lymphoma: A Sin...
Anurag Singh, MD, Clint Divine, MBA, Omar Aljitawi, MD, Sunil Abhyankar, MD, Joseph P. McGuirk, DO, and Siddhartha Ganguly, MD, ASBMT Tandem Meeting, 1/1/2015
In Vivo Purging May Not Be Required In The ERA Of Universal Use Of Rituximab Containing Chemo-Immunotherapy In Patients With Follicular And Mantle Cell Lymphoma: A Sin...
Anurag Singh, MD, Clint Divine, MBA, Omar Aljitawi, MD, Sunil Abhyankar, MD, Joseph P. McGuirk, DO, and Siddhartha Ganguly, MD, Biol Blood Marrow Transplat, 1/1/2015
First Report on an Ongoing Pilot Clinical Study Incorporating Hyperbaric Oxygen into Autologous Peripheral Blood Stem Cell Transplantation
Aljitawi O, Ganguly S, Lin TL, Mahneken J, Palla SL, Bunch J, Supancic S, Singh AK, Shune L, Abhyankar S, Allin D, McGuirk J, ASBMT/CIBMTR Tandem meeting, San Diego, CA, 1/1/2015
First Report on an Ongoing Pilot Clinical Study Incorporating Hyperbaric Oxygen into Autologous Peripheral Blood Stem Cell Transplantation
Aljitawi O, Ganguly S, Lin TL, Mahneken J, Palla SL, Bunch J, Supancic S, Singh AK, Shune L, Abhyankar S, Allin D, McGuirk J, Biol Blood Marrow Transplat, 1/1/2015
Adequacy of Peripheral Blood Stem Cell Mobilization in Patients with Relapsed B Cell Non Hodgkin Lymphoma Treated with Bendamustine: A Pilot Project and a Proof of Con...
Andrew Iliff, MD, Clint Divine, BA, Francisco Diaz, PhD, Omar Aljitawi, MD, Sunil Abhayankar, MD, Joseph McGuirk, DO, and Siddhartha Ganguly, MD, FACP, EBMT, Istanbul, Turkey, 1/1/2015
Analysis of Immunological changes occurring in the peripheral blood of patients treated with extra corporal photopheresis (ECP) for chronic graft versus host disease (...
Sunil Abhyankar, Thomas Yankee, Jignesh Dalal, Omar Aljitawi, Siddhartha Ganguly, Joseph McGuirk, EBMT, Istanbul, Turkey, 1/1/2015
Trisha Home, Sumedha Gunewardena, Joseph McGurik and Rekha Rao. Synergistic Interaction of Auranofin with PARP inhibitors in ATM-proficient Mantle Cell Lymphoma
Siddhartha Ganguly, Siddhartha Ganguly, Philadelphia, PA, 1/1/2015
Join now to see all

Lectures

Disparities in Multiple Myeloma Care in Rural America
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
Immune Profiling of Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide and Low-Dose Dexamethasone in Combination with Daratumumab
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Immunotherapy and targeted therapy
Joplin, MO - 1/28/2016
Updates in Myeloma
Multiple Locations, 2010, 2011, 2015, 2016 - 1/1/2016
Immunotherapy for Heme Malignancies
Honolulu, HI, 2016; Garden City, KS, 2016 - 1/1/2016
Updates in Lymphoma: Ask an Expert
1/1/2016
A Primer on Myeloma
1/1/2016
Myeloma 101
1/1/2016
Cure for Myeloma
1/1/2016
Myeloma Update
Vellore, India, 2015; Kolkata, India, 2015 - 1/29/2015
Role of Post-Transplant Maintenance in Hodgkin’s Disease
Orlando, FL - 1/24/2015
Immunotherapy in Hematology
Salina, KS - 1/6/2015
Immunotherapy and Signal inhibition in Oncology
Memphis, TN - 1/2/2015
Myeloma: Is there a Cure?
1/2/2015
Updates in Lymphoma
Coffeyville, KS - 1/1/2015
BMT 201: Myeloma
Kansas City, KS - 1/1/2014
ASH Update
Kansas City, KS - 1/1/2013
ASBMT Update-Lymphoma
Kansas City, KS - 1/1/2013
Subsequent Hematopoietic Stem Cell Transplantation (HSCT) Associated with Longer Survival in Patients with Relapsed/Refractory (R/R) Acute Myelogenous Leukemia (AML) ...
San Diego, CA, 2012; Kolkata, India, 2012 - 1/19/2012
ASH update in Upfront Treatment of Multiple Myeloma
1/1/2012
GI Manifestations of HSCT
1/1/2012
Cytogenetics
Multiple Locations, 2012 - 1/1/2012
AML/MDS/BMT
Multiple Locations, 2012 - 1/1/2012
Anemia, Bleeding Disorders
1/1/2012
BK Virus
Kansas City, KS - 1/1/2010
Join now to see all

Other

Cytogenetics in Hematology
Siddhartha Ganguly
1/1/2014
Bone Marrow Transplant Algorithm and Standard Operating Procedure
Siddhartha Ganguly
1/1/2011
Blood and Lymph Module, Formative and Summative quiz, PBL, Small Group Discussion
Siddhartha Ganguly
1/1/2009
Arrange/assess for CME’s and Educational Activity Needs for the Division
Siddhartha Ganguly
1/1/2008
Reviewer of Hematology (ABIM) questions
Siddhartha Ganguly
1/1/2007
Hematology Pink Book and Online Formulary
Siddhartha Ganguly
1/1/2007
Policies & Procedures of Factor rVIIa use in University of Kansas Medical Center
Siddhartha Ganguly
1/1/2005
Board Review courses in Hematology
Siddhartha Ganguly
Pre and Post tests in Hematology
Siddhartha Ganguly
Hematology rotation objectives
Siddhartha Ganguly
Blood and Lymph Module with questions, quiz, PBL, Online Resources
Siddhartha Ganguly
Join now to see all